Zobrazeno 1 - 10
of 99
pro vyhledávání: '"P. W. Lücker"'
Publikováno v:
Alimentary Pharmacology & Therapeutics. 12:1027-1032
Background: Pantoprazole is a proton pump inhibitor characterized by a low potential to interact with the cytochrome P450 system, and linear pharmacokinetics. The recommended oral dose for treatment of acid-related diseases is 40 mg. Methods: Using a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dae6c3eb1c2efc2f8d4dfdefe406e7e
https://doi.org/10.1046/j.1365-2036.1998.00406.x
https://doi.org/10.1046/j.1365-2036.1998.00406.x
Publikováno v:
Pharmaceutical Research. 11:151-155
The influence of a fat-rich meal on the pharmacokinetics of cyclosporine from a new oral formulation (Sandimmune Neoral) was compared in a randomized, four-way crossover study to the currently marketed formulation (Sandimmune) in 24 healthy male volu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::396022f8dd17a6010fd9f31d925d33ce
https://doi.org/10.1023/a:1018922517162
https://doi.org/10.1023/a:1018922517162
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 25(8)
Acetylsalicylic acid (ASA) and pseudoephedrine (PSE) are often administered together for the treatment of symptoms of the common cold, i.e., nasal congestion, runny nose, sore throat and headache. Based on this fact we developed a fixed combination o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cea48cd50d17e63f52f8d7efff64dda3
https://pubmed.ncbi.nlm.nih.gov/14671681
https://pubmed.ncbi.nlm.nih.gov/14671681
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 23(1)
The aim of this study was to determine the bioavailability of orally administered, crushed pantoprazole tablets after buffering with either 1.4% sodium hydrogencarbonate or 1600 mg magaldrate relative to the intact enteric coated pantoprazole tablet.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc7b8394c44f0dcba79c1dbc5032f8b
https://pubmed.ncbi.nlm.nih.gov/11413863
https://pubmed.ncbi.nlm.nih.gov/11413863
Publikováno v:
Arzneimittel-Forschung. 49(7)
In an open trial with 18 healthy male volunteers (21-45 years old) the effect of processed (test) and non-processed (reference) coffee samples of same origin on the gastric potential difference (GPD) was studied. Test coffee samples were processed wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afe3d460891b4a50d174b4e50a2cfd17
https://pubmed.ncbi.nlm.nih.gov/10442212
https://pubmed.ncbi.nlm.nih.gov/10442212
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 21(1)
The effects on intragastric p11 and gastrin secretion of once daily pantoprazole (40 mg) and a new formulation omeprazole (20 mg) in a Multiple Unit Pellet System (MUPS) were investigated during two treatment periods of 7 days each in a randomized cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::806b1d550eb535ce6d683e3049f82832
https://pubmed.ncbi.nlm.nih.gov/10222447
https://pubmed.ncbi.nlm.nih.gov/10222447
Autor:
M, Hartmann, A, Ehrlich, H, Fuder, R, Lühmann, S, Emeklibas, W, Timmer, W, Wurst, P W, Lücker
Publikováno v:
Alimentary pharmacologytherapeutics. 12(10)
Pantoprazole is a proton pump inhibitor characterized by a low potential to interact with the cytochrome P450 system, and linear pharmacokinetics. The recommended oral dose for treatment of acid-related diseases is 40 mg.Using a randomized, crossover
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ecdbbfbca2a53713ca78b7c74549849d
https://pubmed.ncbi.nlm.nih.gov/9798809
https://pubmed.ncbi.nlm.nih.gov/9798809
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 20(2)
The gastric irritation potential of orally administered coffee (150 ml) was investigated in four healthy volunteers by continuous measurement of gastric potential difference (GPD) and intragastric pH. Furthermore, serum gastrin concentrations were me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc8de3f56624d8459eb3aa124fe49a4
https://pubmed.ncbi.nlm.nih.gov/9604858
https://pubmed.ncbi.nlm.nih.gov/9604858
Autor:
S. S. Preisig-Flückiger, B. L. Holt, John M. Kovarik, Y. Üresin, P. W. Lücker, E A Mueller, S. Hensel
Publikováno v:
Journal of clinical pharmacology. 37(11)
Valspodar is a cyclosporine D analog used as a chemotherapy adjunct for modifying multidrug resistance. Two studies were sequentially performed to select an optimal oral formulation and to characterize selected aspects of its clinical pharmacokinetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8aff1c5409ef9bfe98f40eccf6336b
https://pubmed.ncbi.nlm.nih.gov/9505992
https://pubmed.ncbi.nlm.nih.gov/9505992